Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
